These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4383600)

  • 21. [Comparison of the effects of alkylating agents, antimetabolites and antineoplastic agents of other types on hemopoietic CFU in mice].
    Massa G; Saviane A; Bogliolo G; Pannacciulli I
    Boll Soc Ital Biol Sper; 1976 Mar; 52(6):460-4. PubMed ID: 949425
    [No Abstract]   [Full Text] [Related]  

  • 22. [Formation of precipitation areas in immunization with the alkylating compounds Lonin-3 and K-4].
    Montsevichiute-Eringene
    Biull Eksp Biol Med; 1968 Mar; 65(3):91-4. PubMed ID: 4967813
    [No Abstract]   [Full Text] [Related]  

  • 23. [Membrane mechanisms of the effect of alkylating cytostatic agents].
    Mukhin VV; Poda GI; Luĭk AI; Baldenkov GN
    Biull Eksp Biol Med; 1990 Apr; 109(4):351-3. PubMed ID: 2386826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Repair of DNA-protein cross-links induced by antineoplastic alkylating agents].
    Lomova TIu; Shakhova IK; Shkodinskaia EN
    Biull Eksp Biol Med; 1981 Jul; 92(7):74-6. PubMed ID: 7295949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review.
    Waxman DJ
    Cancer Res; 1990 Oct; 50(20):6449-54. PubMed ID: 2208103
    [No Abstract]   [Full Text] [Related]  

  • 26. Sites in nucleic acids reacting with alkylating agents of differing carcinogenicity of mutagenicity.
    Singer B
    J Toxicol Environ Health; 1977 Jul; 2(6):1279-95. PubMed ID: 328918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biology of alkylating-agent cellular injury.
    Shulman LN
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):325-35. PubMed ID: 8468267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparative analysis of the antiblastic and immunodepressive effect of alkylating agents].
    Kovalev IE; Chernov VA; Maĭskaia LM
    Vopr Onkol; 1969; 15(6):62-4. PubMed ID: 5811126
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cancerogenicity of cytostatics].
    Hartwich G
    Med Klin; 1971 Oct; 66(43):1433-4. PubMed ID: 4108228
    [No Abstract]   [Full Text] [Related]  

  • 30. Attempt to establish a correlation between the alkylation ability and antitumor activity of some bis(2-chloroethyl)aminoethyl esters of carboxylic acids.
    Manolov I; Golovinsky EV
    Pharmazie; 1988 Mar; 43(3):218-9. PubMed ID: 3380873
    [No Abstract]   [Full Text] [Related]  

  • 31. [DPN content, nucleic acid content and cell structure of ascites tumor cells after administration of alkylating cytostatics].
    DOLD U; MIELSCH M; HOLZER H
    Z Krebsforsch; 1962; 65():139-46. PubMed ID: 14028420
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM).
    Lemoli RM; Visani G; Tosi P; Mazza P; Motta MR; Rizzi S; Zinzani PL; Poluzzi C; Gherlinzoni F; Tura S
    Haematologica; 1988; 73(3):195-200. PubMed ID: 3139515
    [No Abstract]   [Full Text] [Related]  

  • 33. [THE EFFECT OF ALKYLATING CYTOSTATICS ON THE NUCLEIC ACID METABOLISM OF EHRLICH ASCITES TUMOR CELLS].
    LISS E; PALME G
    Z Krebsforsch; 1964 Jul; 66():196-206. PubMed ID: 14256642
    [No Abstract]   [Full Text] [Related]  

  • 34. Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells.
    Denny WA; Wilson WR
    J Med Chem; 1986 Jun; 29(6):879-87. PubMed ID: 3712377
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of action of antileukemic agents and their clinical effects.
    Nakamura T; Tatsumi K; Higuchi T; Shirakawa S; Wakisaka G
    Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):302-15. PubMed ID: 4479921
    [No Abstract]   [Full Text] [Related]  

  • 36. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV; Eremeeva AA; Tereshin IM
    Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacodynamic effect of alkylating cytostatics].
    Maass H
    Dtsch Med J; 1968 Mar; 19(5):137-41. PubMed ID: 4887779
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mixed, Yoshida-type tumors, resistant and sensitive to alkylating agents].
    Winkler A; Ujházy V; Sándor L; Drahovský D
    Cas Lek Cesk; 1966 Sep; 105(39):1068-71. PubMed ID: 5976461
    [No Abstract]   [Full Text] [Related]  

  • 39. Antineoplastic agents and the liver.
    Ménard DB; Gisselbrecht C; Marty M; Reyes F; Dhumeaux D
    Gastroenterology; 1980 Jan; 78(1):142-64. PubMed ID: 7350020
    [No Abstract]   [Full Text] [Related]  

  • 40. The contribution of alkylation to the activity of quinone antitumor agents.
    Begleiter A
    Can J Physiol Pharmacol; 1986 May; 64(5):581-5. PubMed ID: 3730943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.